Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Mar 7;13(6):1524.
doi: 10.3390/jcm13061524.

Pharmacological Interventions in Paraphilic Disorders: Systematic Review and Insights

Chiara Culos  1 , Massimo Di Grazia  1   2 , Paolo Meneguzzo  3   4
Affiliations
Review

Pharmacological Interventions in Paraphilic Disorders: Systematic Review and Insights

Chiara Culos et al. J Clin Med. .

Abstract

(1) Background: Paraphilic disorders, marked by intense sexual fantasies and behaviors, present formidable challenges. This review addresses concerns fueled by scandals and child abuse. Emphasizing paraphilias' complexity, it systematically reviews the pharmacotherapy literature, aiming to enhance understanding and guide future research. (2) Methods: A comprehensive search from 1990 to 2023 across major databases identified 28 relevant English-language studies. Inclusion criteria focused on adult pharmacotherapy for paraphilias, and results were evaluated using the Newcastle-Ottawa Scale. (3) Results: Synthesizing data from selected studies, diverse treatments such as SSRIs and antiandrogens were analyzed, revealing variable effectiveness and side effect profiles. Poor quality of the current literature has been reported. (4) Conclusions: Highlighting the pivotal role of the serotonergic system, this review underscores the efficacy of SSRIs and androgen deprivation therapy. GnRH analog-associated side effects and the importance of a combined assessment approach are discussed. Critical insights contribute to understanding and ethical considerations in paraphilic disorders.

Keywords: paraphilic disorders; pharmacotherapy; serotonergic system; side effects.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
The PRISMA flowchart of the revision.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Beech A.R., Miner M.H., Thornton D. Paraphilias in the DSM-5. Annu. Rev. Clin. Psychol. 2016;12:383–406. doi: 10.1146/annurev-clinpsy-021815-093330. - DOI - PubMed
    1. Krueger R.B., Kaplan M.S. The paraphilic and hypersexual disorders: An overview. J. Psychiatr. Pract. 2001;7:391–403. doi: 10.1097/00131746-200111000-00005. - DOI - PubMed
    1. Turner D., Petermann J., Harrison K., Krueger R., Briken P. Pharmacological treatment of patients with paraphilic disorders and risk of sexual offending: An international perspective. World J. Biol. Psychiatry. 2017;20:616–625. doi: 10.1080/15622975.2017.1395069. - DOI - PubMed
    1. Walton M.T., Cantor J.M., Bhullar N., Lykins A.D. Hypersexuality: A critical review and introduction to the “sexhavior cycle”. Arch. Sex. Behav. 2017;46:2231–2251. doi: 10.1007/s10508-017-0991-8. - DOI - PubMed
    1. Tozdan S., Briken P. Paraphilias: Diagnostics, Comorbidities, and Treatment. In: Lew-Starowicz M., Giraldi A., Krüger T.H.C., editors. Psychiatry and Sexual Medicine: A Comprehensive Guide for Clinical Practitioners. Springer International Publishing; Cham, Switzerland: 2021. pp. 407–416. - DOI

Grants and funding

This research received no external funding.

LinkOut - more resources